Macular Degeneration - Drug therapy
Research News and Information

Sunday, November 22, 2009

The use of intraocular corticosteroids.

29 Sep 2009 BACKGROUND: Diabetic macular edema (DME), cystoid macular edema (CME), age-related macular degeneration (AMD), retinal vascular occlusion (RVO) and uveitis are responsible for severe visual impairment worldwide. In some patients with these ... Read more...

Antiangiogenic approaches to age-related macular degeneration today.

29 Sep 2009 Intravitreal ranibizumab reduces the risk of visual acuity loss and increases the chance of visual acuity gain compared with no treatment or photodynamic therapy for selected cases of subfoveal choroidal neovascularization (CNV) in age-related ... Read more...

Photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: a randomized clinical trial.

10 Sep 2009 PURPOSE: To evaluate the efficacy of intravitreal triamcinolone acetonide (ITA) as an adjunct to photodynamic therapy with verteprofin (VPDT) in the treatment of predominantly classic, subfoveal choroidal neovascularization (CNV) owing to ... Read more...

Latest indexed articles for 'Macular Degeneration - Drug therapy'

These are the very latest articles for this heading:

• Bevacizumab local complications. 30 Oct 2009
• The use of intraocular corticosteroids. 29 Sep 2009
• Issues involving the management of the visually impaired patient. 29 Sep 2009
• Antiangiogenic approaches to age-related macular degeneration today. 29 Sep 2009
• Photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: a randomized clinical trial. 10 Sep 2009
• One-year results of intravitreal ranibizumab for neovascular age-related macular degeneration and clinical responses of various subgroups. 6 Sep 2009
• Intravitreal triamcinolone acetonide preceding photodynamic therapy for exudative age-related macular degeneration. 30 Aug 2009
• Foveal geographic atrophy following intravitreal pegaptanib sodium (Macugen) for drusenoid pigment epithelium detachment. 30 Aug 2009
• Optical coherence tomography in neovascular age related macular degeneration compared to fluorescein angiography and visual acuity. 30 Aug 2009
• Subconjunctival mycetoma after sub-Tenon's corticosteroid injection. 30 Aug 2009
• Combined cataract extraction and intravitreal bevacizumab in eyes with choroidal neovascularization resulting from age-related macular degeneration. 30 Aug 2009
• Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. 30 Aug 2009
• Cerebrovascular accidents and ranibizumab. 30 Aug 2009
• Tachyphylaxis and bevacizumab. 30 Aug 2009
• Age-related macular degeneration and cardiovascular disease in the era of anti-vascular endothelial growth factor therapies. 30 Aug 2009
• Safety implications of vascular endothelial growth factor blockade for subjects receiving intravitreal anti-vascular endothelial growth factor therapies. 24 Aug 2009
• A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration. 20 Aug 2009
• Monitoring ocular drug therapy by analysis of aqueous samples. 20 Aug 2009
• Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration. 16 Aug 2009
• Changes in aqueous vascular endothelial growth factor and pigment epithelium-derived factor after ranibizumab alone or combined with verteporfin for exudative age-related macular degeneration. 9 Aug 2009

See a longer list of these articles.

Technical information about 'Macular Degeneration'

Definition: Degenerative changes in the macula lutea of the retina.

Descriptor UI: D008268

Alternative terms: Macular Degeneration; Degeneration, Macular; Degenerations, Macular; Macular Degenerations; Age-Related Maculopathy; Age Related Maculopathy; Age-Related Maculopathies; Age Related Maculopathies; Maculopathies, Age-Related; Maculopathies, Age Related; Maculopathy, Age-Related; Maculopathy, Age Related;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C11.768.585.439;

Online Note: search RETINAL DEGENERATION 1970-74

History Note: 79(75); was see under RETINAL DEGENERATION 1970-78

Technical Notes: macular refers to macula lutea of retina; includes "macular dystrophy"